IT1303692B1 - Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. - Google Patents
Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.Info
- Publication number
- IT1303692B1 IT1303692B1 IT1998MI002364A ITMI982364A IT1303692B1 IT 1303692 B1 IT1303692 B1 IT 1303692B1 IT 1998MI002364 A IT1998MI002364 A IT 1998MI002364A IT MI982364 A ITMI982364 A IT MI982364A IT 1303692 B1 IT1303692 B1 IT 1303692B1
- Authority
- IT
- Italy
- Prior art keywords
- preparation
- suspensions
- particles
- inhalation
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Priority Applications (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002364A IT1303692B1 (it) | 1998-11-03 | 1998-11-03 | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
BRPI9917701A BRPI9917701B1 (pt) | 1998-11-03 | 1999-10-28 | processo para a esterilização do dipropionato de beclometasona micronizado e dipropionato de beclometasona micronizado estéril terapeuticamente aceitável |
SK94-2006A SK288316B6 (sk) | 1998-11-03 | 1999-10-28 | Spôsob prípravy vodnej suspenzie obsahujúcej beklometazón- dipropionát ako aktívnu zložku vo forme častíc veľkosti vhodnej na pľúcnu alebo nosovú inhaláciu |
CA002349268A CA2349268C (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
EP06017746.6A EP1832279B1 (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
SI9930948T SI1126823T1 (sl) | 1998-11-03 | 1999-10-28 | Postopek za pripravo sterilnega, farmacevtsko sprejemljivega beklometazon-dipropionata |
DE69935002T DE69935002T2 (de) | 1998-11-03 | 1999-10-28 | Verfahren zur Herstellung eines sterilen therapeutisch verträglichen Beclomethasondipropionats |
PL99347908A PL195908B1 (pl) | 1998-11-03 | 1999-10-28 | Sposób wytwarzania sterylnego dipropionianu beklometazonu i sposób wytwarzania wodnej zawiesiny sterylnego dipropionianu beklometazonu |
KR1020017005023A KR100783096B1 (ko) | 1998-11-03 | 1999-10-28 | 흡입운반을 위한 약제입자의 현탁물 제조방법 및 이를 이용한 무균화된 미분화 베클라메타손 디프로피오네이트 |
AT99955895T ATE352288T1 (de) | 1998-11-03 | 1999-10-28 | Verfahren zur herstellung von pharmazeutisch akzeptierbares und steriles beclomethasone dipropionate |
EA200100397A EA003228B1 (ru) | 1998-11-03 | 1999-10-28 | Способ приготовления суспензий лекарственных частиц для доставки путем ингаляции |
DK06017746.6T DK1832279T3 (en) | 1998-11-03 | 1999-10-28 | Process for preparing suspensions containing active substance particles for use by inhalation administration |
CA2614633A CA2614633C (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
TR2001/01209T TR200101209T2 (tr) | 1998-11-03 | 1999-10-28 | Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem |
EP99955895A EP1126823B1 (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of sterile therapeutically acceptable beclomethasone dipropionate |
CNB998129348A CN1158997C (zh) | 1998-11-03 | 1999-10-28 | 一种制备用于吸入给药的药物颗粒悬浮体的方法 |
HU0104230A HU226734B1 (en) | 1998-11-03 | 1999-10-28 | Process for the preparation of suspension containing micronised form of beclometasone dipropionate for inhalation use |
PCT/EP1999/008176 WO2000025746A2 (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
HU0700446A HU230121B1 (hu) | 1998-11-03 | 1999-10-28 | Eljárás inhalációs adagolásra alkalmas hatóanyagszemcsék szuszpenzióinak előállítására |
DK99955895T DK1126823T3 (da) | 1998-11-03 | 1999-10-28 | Fremgangsmåde til fremstilling af sterilt terapeutisk acceptabelt beclometason-dipropionat |
AU12666/00A AU762367B2 (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
US09/830,884 US6464958B1 (en) | 1998-11-03 | 1999-10-28 | Process for the preparation of suspensions of drug particles for inhalation delivery |
BRPI9915251A BRPI9915251B8 (pt) | 1998-11-03 | 1999-10-28 | um processo para a preparação de suspensões de partículas de medicamentos para serem administradas por inalação |
CZ20011541A CZ300650B6 (cs) | 1998-11-03 | 1999-10-28 | Zpusob výroby lécebne prijatelného sterilního dipropionátu beclomethasonu |
PT99955895T PT1126823E (pt) | 1998-11-03 | 1999-10-28 | Processo para a preparação de suspensões de partículas de fármaco para a administração por meio de inalação |
CZ2007-211A CZ2007211A3 (cs) | 1998-11-03 | 1999-10-28 | Způsob přípravy suspenze částic |
JP2000579190A JP2002528484A (ja) | 1998-11-03 | 1999-10-28 | 吸入搬送用薬剤粒子の懸濁液を製造する方法 |
ES99955895T ES2281197T3 (es) | 1998-11-03 | 1999-10-28 | Procedimiento de preparacion de dipropionato de beclometasona esteril farmaceuticamente aceptable. |
SK593-2001A SK285487B6 (sk) | 1998-11-03 | 1999-10-28 | Spôsob prípravy sterilného terapeuticky prijateľného beclometazón-dipropionátu vo forme mikronizovaného prášku a jeho vodnej suspenzie na aerosólovú inhaláciu |
NZ511305A NZ511305A (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
ZA200103526A ZA200103526B (en) | 1998-11-03 | 2001-05-02 | A process for the preparation of suspensions of drug particles for inhalation delivery. |
NO20012175A NO20012175L (no) | 1998-11-03 | 2001-05-02 | Fremgangsmåte for fremstilling av suspensjoner av legemiddelpartikler for inhalering |
CY20071100437T CY1107659T1 (el) | 1998-11-03 | 2007-03-29 | Μεθοδος για την παρασκευη στειρας θεραπευτικως αποδεκτης διπροπιονικης μπεκλομεθαζονης |
CY20151100651T CY1116943T1 (el) | 1998-11-03 | 2015-07-23 | Μεθοδος για την παρασκευη εναιωρηματων σωματιδιων δραστικης ουσιας για χορηγηση δια εισπνοης |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002364A IT1303692B1 (it) | 1998-11-03 | 1998-11-03 | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI982364A1 ITMI982364A1 (it) | 2000-05-03 |
IT1303692B1 true IT1303692B1 (it) | 2001-02-23 |
Family
ID=11380994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT1998MI002364A IT1303692B1 (it) | 1998-11-03 | 1998-11-03 | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
Country Status (26)
Country | Link |
---|---|
US (1) | US6464958B1 (it) |
EP (2) | EP1832279B1 (it) |
JP (1) | JP2002528484A (it) |
KR (1) | KR100783096B1 (it) |
CN (1) | CN1158997C (it) |
AT (1) | ATE352288T1 (it) |
AU (1) | AU762367B2 (it) |
BR (2) | BRPI9915251B8 (it) |
CA (2) | CA2349268C (it) |
CY (2) | CY1107659T1 (it) |
CZ (2) | CZ300650B6 (it) |
DE (1) | DE69935002T2 (it) |
DK (2) | DK1832279T3 (it) |
EA (1) | EA003228B1 (it) |
ES (1) | ES2281197T3 (it) |
HU (2) | HU226734B1 (it) |
IT (1) | IT1303692B1 (it) |
NO (1) | NO20012175L (it) |
NZ (1) | NZ511305A (it) |
PL (1) | PL195908B1 (it) |
PT (1) | PT1126823E (it) |
SI (1) | SI1126823T1 (it) |
SK (2) | SK285487B6 (it) |
TR (1) | TR200101209T2 (it) |
WO (1) | WO2000025746A2 (it) |
ZA (1) | ZA200103526B (it) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0810853B1 (en) * | 1995-02-24 | 2004-08-25 | Elan Pharma International Limited | Aerosols containing nanoparticle dispersions |
RU2236847C2 (ru) | 1998-11-02 | 2004-09-27 | Илан Корпорейшн, Плк. | Композиции в виде множества частиц с модифицированным высвобождением |
AUPQ573300A0 (en) * | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
NZ523693A (en) * | 2000-07-10 | 2004-08-27 | Chiron Corp | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
SG98420A1 (en) * | 2000-07-13 | 2003-09-19 | Purzer Pharmaceutical Co Ltd | Method for transferring one or more active ingredients between different phase carriers |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030091513A1 (en) * | 2001-10-03 | 2003-05-15 | Mohsen Nahed M. | Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension or dispersion media |
US20030129242A1 (en) * | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
WO2003070285A1 (en) | 2002-02-19 | 2003-08-28 | Resolution Chemicals Limited | Solvent-based sterilisation of pharmaceuticals |
ITMI20020808A1 (it) * | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
EP1556091A1 (en) * | 2002-10-04 | 2005-07-27 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
ITMI20022674A1 (it) * | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
US20040208833A1 (en) * | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
ATE426398T1 (de) * | 2003-02-20 | 2009-04-15 | Constant Res & Dev Ltd | Prozess zur herstellung einer dexamethason enthaltenden formulierung zur oralen anwendung |
EP1454636A1 (en) * | 2003-03-04 | 2004-09-08 | Dompé S.P.A. | Sterilization of glucocorticoid drug particles for pulmonary delivery |
US9808471B2 (en) * | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US7811606B2 (en) * | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
WO2004105809A1 (en) * | 2003-05-22 | 2004-12-09 | Elan Pharma International Ltd. | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
GB0319500D0 (en) * | 2003-08-19 | 2003-09-17 | Resolution Chemicals Ltd | Particle-size reduction apparatus,and use thereof |
ITMI20032054A1 (it) | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
US20070267032A1 (en) * | 2003-11-18 | 2007-11-22 | Yansong Shan | Healthy Pleasurable Inhalation Device |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
US7892483B2 (en) * | 2004-03-12 | 2011-02-22 | Cipla Limited | Sterilization process |
GB0406515D0 (en) * | 2004-03-23 | 2004-04-28 | Novartis Ag | Organic compounds |
CA2559915C (en) | 2004-03-23 | 2013-07-02 | Novartis Ag | Micronization of pharmaceutically active agents |
ITMI20040795A1 (it) * | 2004-04-23 | 2004-07-23 | Eratech S R L | Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa |
GB0410995D0 (en) * | 2004-05-17 | 2004-06-23 | Norton Healthcare Ltd | Heat sterilization of glucocorticosteroids |
GB0425266D0 (en) | 2004-11-16 | 2004-12-15 | Norton Healthcare Ltd | Pharmaceutical manufacturing process |
KR20130030305A (ko) * | 2004-11-16 | 2013-03-26 | 엘란 파마 인터내셔널 리미티드 | 주사가능한 나노입자형 올란자핀 제형 |
GB0427568D0 (en) | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
EP1683514B1 (en) | 2005-01-20 | 2012-05-23 | Eratech S.r.l. | Process for the preparation of concentrated suspensions of drugs and kit thereof |
WO2007062685A1 (en) | 2005-11-29 | 2007-06-07 | Farmabios S.P.A. | Process for the preparation of micronised sterile steroids |
AU2007272501A1 (en) * | 2006-07-12 | 2008-01-17 | Elan Pharma International Limited | Nanoparticulate formulations of modafinil |
PT2229148E (pt) * | 2007-12-13 | 2014-05-26 | Novartis Ag | Processo para preparação de uma substância farmacológica particulada e substancialmente cristalina |
CN102448498A (zh) * | 2009-05-25 | 2012-05-09 | 奇斯药制品公司 | 包括肺表面活性物质和类固醇的治疗组合 |
ME02586B (me) | 2011-05-03 | 2017-06-20 | Chiesi Farm Spa | Unapređena suspendovana formulacija beklometazon dipropionata za administraciju putem inhalacije |
ES2545854T3 (es) | 2011-05-04 | 2015-09-16 | Chiesi Farmaceutici S.P.A. | Una formulación tópica que comprende un corticosteroide como ingrediente activo |
CN104739811A (zh) * | 2015-02-27 | 2015-07-01 | 上海臣邦医药科技有限公司 | 一种糖皮质激素雾化吸入混悬液及其制备方法 |
TWI773641B (zh) * | 2015-05-08 | 2022-08-11 | 日商活效製藥股份有限公司 | 含有糖皮質類固醇(glucocorticoids)之奈米微粒子之水性懸浮液劑 |
WO2023136787A1 (en) * | 2022-01-17 | 2023-07-20 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of a sterile, homogeneous suspension for inhalation by nebulization |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0416950T3 (da) * | 1989-09-08 | 1993-10-11 | Glaxo Group Ltd | Medikamenter |
US5126123A (en) * | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
JPH0486921A (ja) * | 1990-07-31 | 1992-03-19 | Omron Corp | 近似推論のための知識ベース形成方法および装置 |
US5046326A (en) | 1990-10-24 | 1991-09-10 | Thermo King Corporation | Transport refrigeration system |
IT1243911B (it) * | 1990-11-19 | 1994-06-28 | Zambon Spa | Composizioni per la terapia mucolitica |
GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
IL101387A (en) * | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
UY24147A1 (es) * | 1995-01-20 | 1996-02-02 | Gruenenthal Chemie | Procedimiento y dispositivo para preparar composiciones dispersables por aspersion de aerosoles |
US6135628A (en) * | 1995-10-13 | 2000-10-24 | Boehringer Ingelheim Pharmceuticals, Inc. | Method and apparatus for homogenizing aerosol formulations |
IT1286496B1 (it) * | 1996-11-20 | 1998-07-15 | Leetrim Ltd Dublin | Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria |
SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
-
1998
- 1998-11-03 IT IT1998MI002364A patent/IT1303692B1/it active
-
1999
- 1999-10-28 EP EP06017746.6A patent/EP1832279B1/en not_active Expired - Lifetime
- 1999-10-28 HU HU0104230A patent/HU226734B1/hu unknown
- 1999-10-28 EA EA200100397A patent/EA003228B1/ru not_active IP Right Cessation
- 1999-10-28 EP EP99955895A patent/EP1126823B1/en not_active Expired - Lifetime
- 1999-10-28 WO PCT/EP1999/008176 patent/WO2000025746A2/en active Application Filing
- 1999-10-28 AT AT99955895T patent/ATE352288T1/de active
- 1999-10-28 KR KR1020017005023A patent/KR100783096B1/ko active IP Right Grant
- 1999-10-28 DE DE69935002T patent/DE69935002T2/de not_active Expired - Lifetime
- 1999-10-28 CZ CZ20011541A patent/CZ300650B6/cs not_active IP Right Cessation
- 1999-10-28 PT PT99955895T patent/PT1126823E/pt unknown
- 1999-10-28 TR TR2001/01209T patent/TR200101209T2/xx unknown
- 1999-10-28 SK SK593-2001A patent/SK285487B6/sk not_active IP Right Cessation
- 1999-10-28 SK SK94-2006A patent/SK288316B6/sk not_active IP Right Cessation
- 1999-10-28 CA CA002349268A patent/CA2349268C/en not_active Expired - Lifetime
- 1999-10-28 CA CA2614633A patent/CA2614633C/en not_active Expired - Lifetime
- 1999-10-28 NZ NZ511305A patent/NZ511305A/en unknown
- 1999-10-28 CZ CZ2007-211A patent/CZ2007211A3/cs not_active IP Right Cessation
- 1999-10-28 AU AU12666/00A patent/AU762367B2/en not_active Ceased
- 1999-10-28 DK DK06017746.6T patent/DK1832279T3/en active
- 1999-10-28 SI SI9930948T patent/SI1126823T1/sl unknown
- 1999-10-28 PL PL99347908A patent/PL195908B1/pl unknown
- 1999-10-28 US US09/830,884 patent/US6464958B1/en not_active Expired - Lifetime
- 1999-10-28 JP JP2000579190A patent/JP2002528484A/ja active Pending
- 1999-10-28 CN CNB998129348A patent/CN1158997C/zh not_active Expired - Lifetime
- 1999-10-28 BR BRPI9915251A patent/BRPI9915251B8/pt not_active IP Right Cessation
- 1999-10-28 BR BRPI9917701A patent/BRPI9917701B1/pt not_active IP Right Cessation
- 1999-10-28 ES ES99955895T patent/ES2281197T3/es not_active Expired - Lifetime
- 1999-10-28 HU HU0700446A patent/HU230121B1/hu unknown
- 1999-10-28 DK DK99955895T patent/DK1126823T3/da active
-
2001
- 2001-05-02 ZA ZA200103526A patent/ZA200103526B/en unknown
- 2001-05-02 NO NO20012175A patent/NO20012175L/no not_active Application Discontinuation
-
2007
- 2007-03-29 CY CY20071100437T patent/CY1107659T1/el unknown
-
2015
- 2015-07-23 CY CY20151100651T patent/CY1116943T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1303692B1 (it) | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. | |
EP1613280B1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
CH680983A5 (it) | ||
US20040110828A1 (en) | Tetrahydrocannabinol compositions and methods of manufacture and use thereof | |
TW200806318A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
AU1079701A (en) | Oral transmucosal drug dosage using solid solution | |
BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
US20060039871A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
CN107737100A (zh) | 苯二氮卓组合物的投与 | |
US8349888B2 (en) | Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury | |
EP1673074B1 (de) | Flüssige zubereitung enthaltend tobramycin | |
US11903925B2 (en) | Compositions for preventing and treating pulmonary injury due to ionizing radiation or cytotoxic drugs | |
Korani et al. | Parenteral systems for statin delivery | |
JP2002370977A (ja) | 局所適用組成物 | |
JP2001122768A (ja) | 薬物を脳へ送達する粉末状医薬組成物 |